Reorganization of public procurement of biosimilars and its economic effect on the monoclonal antibody market in Russia

Reorganization of public procurement of biosimilars and its economic effect on the monoclonal antibody market in Russia

Background. The increasing number of registered biosimilars of monoclonal antibodies (mAbs) is altering the structure of the pharmaceutical market by amplifying the share of domestic manufacturers. Therefore, investigating their economic effect appears highly relevant.Objective: To examine the impac...

Full description

Saved in:
Bibliographic Details
Main Authors: A. Yu. Efremov, A. M. Vlasov, V. I. Gegechkori, N. V. Gorpinchenko, G. V. Ramenskaya, T. M. Litvinova
Format: Article
Language:Russian
Published: IRBIS LLC 2025-05-01
Series:Фармакоэкономика
Subjects:
monoclonal antibodies
biosimilars
public procurement
pharmaceutical market
Online Access:https://www.pharmacoeconomics.ru/jour/article/view/1145
Tags: Add Tag
No Tags, Be the first to tag this record!

Similar Items

Similar Items